An In-silico Approach to Design and Validate SiRNA against Monkeypox Virus

CONCLUSION: Thus, the strategy may offer a platform for the development of potential antiviral RNA therapeutics that target MPXV at the genomic level.PMID:38062661 | DOI:10.2174/0113816128275065231103063935

Source: Current Pharmaceutical Design - December 8, 2023 Category: Drugs & Pharmacology Authors: Kishore Dhotre Anwesha Banerjee Debashree Dass Vijay Nema Anupam Mukherjee Source Type: research